ESPOSITO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.486
EU - Europa 6.113
AS - Asia 1.260
Continente sconosciuto - Info sul continente non disponibili 26
SA - Sud America 16
AF - Africa 12
OC - Oceania 7
Totale 16.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.443
GB - Regno Unito 2.386
IT - Italia 1.294
SE - Svezia 968
CN - Cina 554
DE - Germania 437
UA - Ucraina 405
TR - Turchia 371
FI - Finlandia 226
HK - Hong Kong 185
BG - Bulgaria 140
FR - Francia 110
IN - India 62
CA - Canada 38
IR - Iran 35
RU - Federazione Russa 35
IE - Irlanda 31
EU - Europa 24
BE - Belgio 20
NL - Olanda 18
SG - Singapore 12
ES - Italia 10
MY - Malesia 10
KR - Corea 9
CH - Svizzera 8
AU - Australia 7
BR - Brasile 7
PK - Pakistan 7
ZA - Sudafrica 7
CO - Colombia 6
SI - Slovenia 6
JP - Giappone 4
PT - Portogallo 4
GR - Grecia 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CL - Cile 2
CU - Cuba 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
MG - Madagascar 2
NO - Norvegia 2
PA - Panama 2
PL - Polonia 2
RO - Romania 2
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
BT - Bhutan 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ID - Indonesia 1
IM - Isola di Man 1
JO - Giordania 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 16.920
Salva come PNG Salva come JPEG
Città #
Southend 2.066
Fairfield 1.105
Woodbridge 1.011
Chandler 918
Jacksonville 789
Houston 664
Ashburn 622
Dearborn 572
Nyköping 514
Wilmington 471
Ann Arbor 449
Cambridge 374
Seattle 373
Beijing 278
Izmir 245
Hong Kong 184
Princeton 147
Sofia 137
Eugene 135
San Diego 118
Des Moines 105
Modena 101
Milan 90
Helsinki 89
New York 82
Rome 66
Shanghai 46
Frankfurt am Main 42
London 37
Philadelphia 34
Bremen 33
Nanjing 32
Boardman 30
Redwood City 29
Dublin 27
Naples 27
Verona 27
Bologna 26
Florence 22
San Mateo 22
Hefei 21
Norwalk 21
Augusta 18
Ottawa 18
Brussels 17
Falls Church 17
Parma 17
Kunming 16
Bari 15
Catania 15
Fremont 14
Grafing 14
Toronto 14
Bangalore 12
Brescia 12
Palermo 12
Auburn Hills 11
Guangzhou 11
Los Angeles 11
Saint Petersburg 11
Bergamo 10
Indiana 10
Jinan 10
Mashhad 10
Monmouth Junction 10
Mumbai 10
Turin 10
Hounslow 9
Kilburn 9
Paris 9
Ardabil 8
Pescara 8
Piacenza 8
Treviso 8
Chiswick 7
Leawood 7
Saint-martin-du-tertre 7
San Jose 7
Amsterdam 6
Kish 6
Napoli 6
Padova 6
Renton 6
Rio Saliceto 6
Sassari 6
Washington 6
Borås 5
East London 5
Genoa 5
Legnano 5
Nanchang 5
Ningbo 5
Pisa 5
Prescot 5
Ravenna 5
Shenyang 5
Vicenza 5
Avellino 4
Cagliari 4
Campobasso 4
Totale 12.708
Salva come PNG Salva come JPEG
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 829
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 228
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease. 225
Gli ascessi epatici nei pazienti sottoposi a trapianto ortotopico di fegato 220
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 200
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 193
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 193
Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomized study. 187
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 186
Efficacy and safety of atazanavir in patients with end-stage liver disease. 186
La clinica metabolica per il trattamento della lipodistrofia 185
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 178
Brucellosis in a patient with end-stage liver disease undergoing liver transplantation: successful treatment with tigecycline. 178
Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients 177
Late presenters in an HIV surveillance system in Italy during the period 1992-2006. 177
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection. 177
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases. 172
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. 172
Differential Dose Adjustments of Immunosuppressants after Resuming Boosted versus Unboosted HIV-Protease Inhibitors Postliver Transplant. 171
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 170
Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation. 166
Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1 165
Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR 165
Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation 164
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study 163
Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naive HIV-positive patients. 161
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: An international observational study 159
Raltegravir and enfuvirtide as a “bridge” antiretroviral therapy in kidney-tranplanted patients with HIV infection receiving everolimus and low-dose cyclosporine: a case-control study 159
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 158
Fatal cytomegalovirus necrotising enteritis in a small bowel transplantation adult recipient with low pp65 antigenaemia levels 157
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 157
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 157
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection 151
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 150
Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy 146
Applicazione della scala di valutazione, Functional indipendence Measure (FIM), per la valutazione dei programmi di riabilitazione per pazienti affetti da AIDS Dementia Complex ospiti di una casa alloggio 143
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease 140
Detectable HIV viral load is associated with metabolic syndrome. 140
Age-related comorbidities in people living with HIV 140
Artropodi vettori di agenti infettivi 140
Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients 139
Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: Report of three cases 138
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 137
Un caso di tubercolosi post-trapianto ortotopico di fegato: limiti dell’impiego del quantiferon-TB gold nella diagnosi della infezione tubercolare latente ed attiva 136
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006). 136
Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. 134
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 133
Body image is a major determinant of sexual dysfunction in stable HIV-infected women. 132
Outcome, incidence, and timing of infections in small bowel/multivisceral transplantation 130
Improving the appropriateness of antibiotic prescription in hospitals: a pilot study assessing the effectiveness of an infectious diseases specialist's consultation programme 128
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 126
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 122
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 119
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 119
Severity of lipodystrophy is associated with decreased health-related quality of life 118
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: The CARe study 118
Pharmacokinetic interaction between amprenavir/ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation 118
Association of serum vitamin D levels nd type 2 diabetes in HIV infection in the Modena cohort 117
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 116
Body Image is a major determinant of sexual dysfunction in stable HIV-infected women. 116
Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study 115
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 114
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 113
Prevalence of secondary causes of osteoporosis among HIV infected individuals 113
Statistical agreement between ATPIII, IDF, EGIR, AACE metabolic syndrome classifications in HIV-infected patients and association with lipodystrophy 113
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 113
Immunophenotype of HIV plus patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system 113
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 112
CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 10(6) cells/I 112
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: The changes in opportunistic prophylaxis study 112
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 110
Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of quantiferon TB GOLD results in the transplant setting: A case report 110
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1 108
Bloodstream infections (BSIs) in Liver Transplant Recipients: Analisys at an Italian Tertiary-Care Hospital 108
Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count grater than 500 cells 108
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 108
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 107
HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. 106
La trasmissione verticale di HIV nell’era della HAART 105
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 105
Assessment of 10-year probability of a major osteoporotic fracture in HIV-infected patients using FRAX® tool algorithms. 102
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 102
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 101
CD4-Guided treatment interruptions: a new possibile therapeutic strategy 101
Studio caso-controllo sui fattori di rischio delle infezioni micotiche nei pazienti sottoposti a trapianto ortotopico di fegato (OLT) da donatore cadavere e da donatore vivente. 100
È possibile un counselling HIV su internet? 100
Relapse of HIV-related buffalo hump after liposuction 100
Validity of body image perception in women with HIV. 99
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 99
Does lipodistrophy affect quality of life? 99
GH response to GH-releasing hormone-arginine (GHRH+Arg) is impaired in women affected by human immunodeficiency virus (HIV)-related lipodystrophy 96
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 95
Pathological fractures in patients with osteopenia and osteoporosis induced by antiretroviral therapy 94
Test di sensibilità antimicotica in vitro su isolati di Candida spp. da emocolture di pazienti ospedalizzati 94
La casa alloggio: ospite, centro riabilitativo o entrambi? 93
Statistical agreement between metabolic syndrome ATP-III, IDF, EGIR and ACE classification in HIV-infected patients and association with body fat redistribution 93
Body Image perception in HIV infected women with body fat redistribution. 92
Body image perception tests for lipodistrophy. 90
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 90
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 90
Totale 14.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.907
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.214 0 0 0 0 0 0 0 0 0 142 469 603
2019/20203.629 322 142 147 254 367 521 577 511 313 95 193 187
2020/20212.617 236 78 182 255 404 230 213 288 133 280 195 123
2021/20222.286 31 374 189 246 53 85 118 177 220 134 367 292
2022/20232.854 300 261 229 240 316 467 46 288 333 55 166 153
2023/20241.417 111 139 122 176 283 151 149 199 52 35 0 0
Totale 17.125